- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Suven Life Sciences' board approved conversion of warrants, allotting ~3.18 Cr equity shares to a promoter entity at Rs. 134/share. This preferential issue injected Rs. 425.70 Cr, increasing the company's paid-up capital to ~26.37 Cr shares.